Fangmin Chen Qihua Gu Chengping Hu Xiaoling Cai Shuhua Lei
10.2147/OTT.S196751
Onco Targets Ther
2019 May 1;12:3321-3325.
alk rearrangement kras mutation chemotherapy crizotinib pulmonary sarcomatoid carcinoma targeted therapy
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/31118683/
Case Reports
PMC6501700
31118683
Poor prognosis of pulmonary sarcomatoid carcinoma with KRAS mutation and ALK fusion
2019